NeuroPace, Inc. (NPCE) DCF Valuation

NeuroPace, Inc. (NPCE) DCF Valuation

US | Healthcare | Medical - Devices | NASDAQ
NeuroPace, Inc. (NPCE) DCF Valuation
  • ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
  • ✓ Professional Design: Trusted, Industry-Standard Templates
  • ✓ Pre-Built For Quick And Efficient Use
  • ✓ No Expertise Is Needed; Easy To Follow

NeuroPace, Inc. (NPCE) Bundle

Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Simplify NeuroPace, Inc. (NPCE) valuation with this customizable DCF Calculator! Featuring real NeuroPace, Inc. (NPCE) financials and adjustable forecast inputs, you can test scenarios and uncover NeuroPace, Inc. (NPCE) fair value in minutes.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue 37.0 41.1 45.2 45.5 65.4 76.1 88.6 103.2 120.1 139.7
Revenue Growth, % 0 11.27 9.83 0.74586 43.72 16.39 16.39 16.39 16.39 16.39
EBITDA -20.1 -12.5 -28.4 -36.6 -22.8 -40.0 -46.6 -54.2 -63.1 -73.4
EBITDA, % -54.28 -30.34 -62.8 -80.33 -34.9 -52.53 -52.53 -52.53 -52.53 -52.53
Depreciation .4 .3 .3 3.0 1.6 1.8 2.1 2.4 2.8 3.2
Depreciation, % 1.14 0.75842 0.65511 6.56 2.45 2.31 2.31 2.31 2.31 2.31
EBIT -20.5 -12.8 -28.7 -39.6 -24.4 -41.8 -48.6 -56.6 -65.8 -76.6
EBIT, % -55.41 -31.1 -63.45 -86.89 -37.36 -54.84 -54.84 -54.84 -54.84 -54.84
Total Cash 5.1 38.1 115.6 77.4 66.5 61.9 72.0 83.8 97.6 113.6
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables 6.0 8.4 7.1 7.5 12.3
Account Receivables, % 16.27 20.41 15.69 16.44 18.82
Inventories 7.9 6.9 7.8 9.7 11.2 14.3 16.7 19.4 22.6 26.3
Inventories, % 21.37 16.79 17.31 21.34 17.14 18.79 18.79 18.79 18.79 18.79
Accounts Payable .9 .9 1.4 2.1 2.3 2.4 2.9 3.3 3.9 4.5
Accounts Payable, % 2.44 2.31 3.05 4.72 3.56 3.22 3.22 3.22 3.22 3.22
Capital Expenditure -.5 -.1 -.4 -.6 -.2 -.6 -.7 -.8 -.9 -1.1
Capital Expenditure, % -1.27 -0.15071 -0.84988 -1.32 -0.26444 -0.77111 -0.77111 -0.77111 -0.77111 -0.77111
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -27.8 -19.0 -30.3 -44.8 -24.4 -41.8 -48.6 -56.6 -65.8 -76.6
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -40.9 -20.0 -29.6 -44.0 -29.2 -44.6 -51.4 -59.8 -69.6 -81.0
WACC, % 12.69 12.69 12.69 12.69 12.69 12.69 12.69 12.69 12.69 12.69
PV UFCF
SUM PV UFCF -209.5
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) -83
Terminal Value -773
Present Terminal Value -425
Enterprise Value -635
Net Debt 54
Equity Value -689
Diluted Shares Outstanding, MM 26
Equity Value Per Share -26.65

What You Will Get

  • Comprehensive NPCE Financials: Access to historical and projected data for precise valuation.
  • Customizable Inputs: Adjust WACC, tax rates, revenue growth, and capital expenditures as needed.
  • Real-Time Calculations: Intrinsic value and NPV are computed automatically.
  • Scenario Analysis: Evaluate various scenarios to assess NeuroPace's future performance.
  • User-Friendly Interface: Designed for professionals while remaining easy to navigate for newcomers.

Key Features

  • 🔍 Real-Life NPCE Financials: Pre-filled historical and projected data for NeuroPace, Inc.
  • ✏️ Fully Customizable Inputs: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
  • 📊 Professional DCF Valuation: Built-in formulas calculate NeuroPace’s intrinsic value using the Discounted Cash Flow method.
  • ⚡ Instant Results: Visualize NeuroPace’s valuation instantly after making changes.
  • Scenario Analysis: Test and compare outcomes for various financial assumptions side-by-side.

How It Works

  • Download: Obtain the pre-formatted Excel file containing NeuroPace, Inc.'s (NPCE) financial data.
  • Customize: Modify projections, including revenue growth, EBITDA %, and WACC to fit your analysis.
  • Update Automatically: The intrinsic value and NPV calculations refresh in real-time.
  • Test Scenarios: Develop various projections and instantly compare the results.
  • Make Decisions: Leverage the valuation outcomes to inform your investment strategies.

Why Choose NeuroPace, Inc. (NPCE)?

  • Innovative Solutions: Cutting-edge technology designed to improve patient outcomes.
  • Proven Effectiveness: Clinical studies demonstrate significant benefits for epilepsy patients.
  • Patient-Centric Approach: Tailored treatments that focus on individual needs and lifestyles.
  • Expert Support: Dedicated team of professionals providing guidance and assistance.
  • Industry Recognition: Trusted by healthcare providers and patients alike for quality and reliability.

Who Should Use NeuroPace, Inc. (NPCE)?

  • Investors: Gain insights into innovative technologies and make informed investment choices.
  • Healthcare Professionals: Understand the benefits of neuromodulation therapies for patient care.
  • Researchers: Explore cutting-edge clinical data and advancements in neurological treatments.
  • Patients and Caregivers: Learn about options for managing epilepsy and improving quality of life.
  • Educators and Students: Utilize resources to enhance knowledge in medical technology and neuroscience.

What the Template Contains

  • Operating and Balance Sheet Data: Pre-filled NeuroPace, Inc. (NPCE) historical data and forecasts, including revenue, EBITDA, EBIT, and capital expenditures.
  • WACC Calculation: A dedicated sheet for Weighted Average Cost of Capital (WACC), including parameters like Beta, risk-free rate, and share price.
  • DCF Valuation (Unlevered and Levered): Editable Discounted Cash Flow models showing intrinsic value with detailed calculations.
  • Financial Statements: Pre-loaded financial statements (annual and quarterly) to support analysis.
  • Key Ratios: Includes profitability, leverage, and efficiency ratios for NeuroPace, Inc. (NPCE).
  • Dashboard and Charts: Visual summary of valuation outputs and assumptions to analyze results easily.

Es wurden keine passenden Produkte gefunden.